-
UK PM unveils plan to help rough sleepers off streets by Christmas
-
Texas Counseling Center Highlights the Role of Counseling in Supporting Immigration Psychological Evaluations
-
Tokyo opposes US sanctions on Japanese ICC chief Akane
-
Pakistan govt to challenge court on moving ex-PM Khan to private hospital
-
Humanoid-maker Unitree surges more than 600% on Shanghai debut
-
India four wickets away from victory in Sri Lanka Test
-
Bowling great Donald warns Bangladesh that Australia will hit back hard
-
Belgian wildfire 'encircled' but situation still 'complicated'
-
STARPRIME Completes Beta Testing of Market-Maker Model for Retail Brokers
-
Southern African mothers plead for sons lured to Russia's war
-
Campaigns kick off in Nigerian presidential race
-
Palestinian-American hoists US flag on home besieged by settlers
-
Aussie Rules club suspends five players for drinking, bringing women to hotel
-
Freedom Holding Marks New Türkiye Milestone as Freedom Yatırım Secures Brokerage License
-
Trump pauses 50% tariffs on Canadian goods for three days
-
Humanoid resources: China's robots search for workforce breakthrough
-
Five Premier League stars to watch this season
-
China goes rural with data centres in quest to power AI
-
China's robots open to opportunities in search of commercial breakthrough
-
Trump pauses planned 50% tariffs on Canadian goods for three days
-
Tech leads losses as Asian stocks track Wall St selloff
-
Ikitau, Suaalii named in Australia squad for Argentina Tests
-
US, South Korea cut drills short after Trump criticism
-
'American Doctor' shows brutality of conflict in Gaza
-
Italian scientists bet on octopus to fight crab invasion
-
New Zealand blocks lawsuits against firms over climate harm
-
New 'Insidious' reflects anxiety of being a new parent: director
-
Aussie Rules club suspends five players amid police probe
-
No.1 Sabalenka slams Wang to advance at Cincinnati
-
No.1 Sabalenka slams Wang to power ahead in Cincinnati
-
Turkey rejects Israeli claims after strike on Syria air base
-
Israel blames Turkey after strike on Syria air base
-
Bioz and InvivoGen Elevate Scientific Discovery with an Expanded Digital Research Experience
-
BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
-
Empire Metals Limited Announces MRE Upgrade at Pitfield Titanium Project
-
Elevate Acquires Lupl
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 19
-
Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai
-
Best Place to Buy Gold IRA in 2026 (Guide Released)
-
Climate change main driver of European ocean warming: study
-
Trump, Carney talk as Canada seeks to hold off new US tariffs
-
Gauff finds a way into the Cincinnati fourth round
-
NASA images reveal crater left by SpaceX rocket's Moon crash
-
ZZ Top drummer Frank Beard dies at age 77
-
UN atomic watchdog says found tons of nuclear material at Syria site
-
Bayern's Musiala reveals 'neurological disorder' after on-field collapse
-
Ecuadoran diplomat enters race to be next UN chief
-
Angelique Kidjo immortalised on Hollywood Walk of Fame
-
US sanctions ICC chief Tomoko Akane of Japan
-
France to expel two Iranian diplomats: foreign minister
Bioz and InvivoGen Elevate Scientific Discovery with an Expanded Digital Research Experience
PALO ALTO, CA / ACCESS Newswire / August 19, 2026 / Bioz, Inc., the scientific marketing platform that transforms peer-reviewed research into evidence-rich product experiences, is proud to announce the expansion of its longstanding partnership with InvivoGen, a leading provider of innovative tools for immunology, cell biology, and innate immune research.
For years, InvivoGen has leveraged Bioz solutions to connect researchers with peer-reviewed scientific evidence supporting its products. Building on this successful collaboration, InvivoGen has expanded its digital experience with the Bioz Content Hub: a centralized, standalone destination that brings relevant scientific publications together in one intuitive research environment.
The Bioz Content Hub gives researchers a powerful place to begin when they are exploring a new scientific question, application, or product category and are unsure where to start. Rather than searching across multiple sources, visitors can browse, search, and filter peer-reviewed publications featuring InvivoGen products, helping them identify relevant research and evaluate product use cases with greater confidence.
Once researchers identify the product best suited to their needs, the Content Hub connects them directly to the relevant InvivoGen product webpage with Bioz Badges present. This seamless path from publication discovery to product exploration helps reduce friction in the purchasing journey, allowing researchers to move efficiently from scientific evidence to an informed purchasing decision.
"Scientific literature plays a critical role in how researchers evaluate the tools they use in their work," said Annie Tiraby-Florette, Marketing Director at InvivoGen. "Our partnership with Bioz enables us to make that evidence more accessible and actionable. The Bioz Content Hub gives researchers an easy starting point for discovering publications relevant to their research, while creating a clear path to the InvivoGen products that can support their experiments."
The Bioz Content Hub is continuously updated as new peer-reviewed research becomes available, ensuring that scientists have access to the latest publications featuring InvivoGen technologies. Early engagement across InvivoGen's research content has already been impressive, demonstrating that researchers value a centralized, evidence-rich resource for exploring scientific applications and product validation.
"Making it easier for researchers to find the right information at the right time has been an important focus of our digital strategy," said Emmanuel Gardette, Webmaster at InvivoGen. "We are very encouraged by the early engagement we are seeing across our research content. The Bioz Content Hub provides a streamlined and intuitive experience where visitors can discover scientific evidence and quickly navigate to the products they need."
"InvivoGen has been a valued Bioz partner, and we are excited to see them expand their use of our platform with the Bioz Content Hub," said Dr. Karin Lachmi, Co-Founder and Chief Revenue Officer at Bioz. "The strong early engagement with their research content reinforces the value of making peer-reviewed scientific evidence easy to discover. Together, we are helping scientists move from questions to validated product decisions more efficiently."
About Bioz
Bioz is the world's most advanced citation-based data platform for scientific research, offering evidence-backed product ratings and recommendations to guide scientists toward the most validated products and services for their discoveries. Bioz's solutions for suppliers include Bioz Badges and Bioz Content Hubs, web-based widgets that enhance user engagement and increase sales conversion.
About InvivoGen
InvivoGen is a global provider of innovative research tools that support scientists working in immunology, cell biology, molecular biology, and related life science fields. The company offers a broad portfolio of products, including innate immune receptor ligands, reporter cell lines, recombinant proteins, antibodies, plasmids, selection antibiotics, and cell culture reagents. By developing high-quality, reliable tools for studying immune signaling pathways and cellular function, InvivoGen helps researchers advance discoveries in areas such as infectious disease, cancer, inflammation, vaccine development, and immunotherapy.
Helpful Links
For more information about Bioz solutions for suppliers, please reach out to [email protected].
SOURCE: Bioz, Inc.
View the original press release on ACCESS Newswire
D.Moore--AMWN